Appropriate Medical Governance at companies is increasing in need, scope, and importance in the industry. The patient is at the core of this. The public, regulators, providers, and markets expect that principles of good medical science and ethical standards are consistently applied globally across the product lifecycle from development to post-marketing surveillance and promotional practices all the way through to product withdrawal.

Medical issues must be identified internally and proactively managed with stakeholders, including regulators, providers, prescribers, and the general public because information travels fast these days – across markets as well as within the public domain over channels like social media.

In order to successfully operate in this environment, companies must be able to navigate through evolving regulatory requirements and have in place:

  • Empowered multi-functional, governance bodies with clear remits
  • Policies that are well-understood and enforceable
  • Compliant processes with well-defined escalation paths
  • Integrated technologies providing accurate, near real-time data from a multitude of sources

Medical Governance must also be risk-based and supported at the Chief Medical Officer (CMO) level. In addition, it is also vital that medical standards are truly global and applied to both partners and local markets, presenting its own set of challenges as companies continually explore sourcing options and expand into new markets.

We are in an era requiring R&D models that not only need internal multi-functional alignment beginning from the earliest phases of development, but also ongoing external engagement with stakeholders who are keen to understand the value of a product based on its benefit-risk profile relative to what is already on the market as well as what will be on the market.

At Navitas, we have worked with companies to ensure medical decisions are consistent throughout the business enabling them to approach external stakeholders with a single voice. From companies that are only in late stage development to those that have marketed products spread across divisions and multiple therapeutic areas, we can help you through this journey and make this change happen.

cmonet

cmonet is the network for Chief Medical Officers to share insights, exchange ideas, and offer peer support. The founding group of CMOs, led by Mike Devoy of Bayer HealthCare, initiated the community given emergent expectations of the role from regulators and the diversity in scope and positioning of the role in the industry.

For more information on cmonet, please click here.


Get in touch


Ready to explore how Navitas can make your business more efficient, proactive, and flexible!

Please feel free to contact us and we will get back to you as soon as possible.

Latest News

24
Jan2017

Navitas Networks announce Forum dates for Spring, 2017

The Navitas Networks are pleased to confirm the dates for our upcoming Spring forums... ...

17
Jan2017

Navitas Launches Labeling Assessment Express

Regulators are changing the way they look at labeling. The emphasis is on ensuring...

02
Nov2016

BioVectra chooses pharmaREADY for eCTD Solution

BioVectra has chosen pharmaREADY for its eCTD requirements. BioVectra, located in Canada, manufactures...

05
Oct2016

Navitas at DIA's 10th Annual Forum for Qualified Persons...

Navitas Principal Jeffrey Ho will present "Efficient content management for the compilation and...

04
Oct2016

News 2016

[row id="1" class="ROW_CLASS"] [col class="span12"] 02 Nov 2016 AbbVie and Navitas Present Case Study on the Evolution...

27
Sep2016

Navitas releases paper on CDISC, the standards and why the...

The FDA (and eventually, regulatory agencies from around the world) will require clinical data...

13
Sep2016

AbbVie and Navitas Present Case Study on the Evolution and...

At 10:30a.m. (East Coast Time) on September 22nd, Navitas and AbbVie will...

29
Jul2016

Navitas Networks announce Forum dates for Autumn, 2016

The Navitas Networks are pleased to confirm the dates for our upcoming Autumn forums....

12
Jul2016

Navitas Celebrates 100th pharmaREADY customer

pharmaREADY is Navitas’ intuitive and easy to use, fully integrated, regulatory compliant, web-based suite...

28
Jun2016

Navitas' PVTech Summit Defines Future Success

Navitas’ PVTech Summit was held on June 15th at the Hudson Hotel in New...

18
May2016

Navitas Welcomes Tara Baer to Navitas

Navitas is pleased to welcome Tara Baer, who joins Navitas' Regulatory Practice. With over...

18
May2016

Navitas Speaks at Sparta Connection in Orlando

David Gwyn, Navitas' Technology Practice lead, will unveil idmpREADY at the Sparta Connection conference...

14
Mar2016

Navitas Earns Speaking Sessions at DIA’s 52nd Annual Meeting

In two different sessions, Subject Matter Experts from Navitas will address new challenges facing...

09
Mar2016

Navitas is pleased to announce the introduction of our networks...

Navitas' inaugural pvindia meeting took place in Mumbai on Thursday 03 March, 2016. ...

25
Jan2016

Navitas Announces the Inaugural pvindia Forum

Navitas will soon be adding to our portfolio of industry leading networks with the...

18
Jan2016

Navitas Relaunches pharmaREADY.com

pharmaREADY.com is Navitas' next generation website for its fully integrated, regulatory compliant document management,...

14
Dec2015

Steve Arlington, Navitas Advisor, Spoke on the Challenges, Opportunities and...

Steve Arlington, Navitas Advisor, Spoke on the Challenges, Opportunities and Future of the Pharmaceutical...

03
Nov2015

The changing trends in drivers of life sciences R D...

Outsourcing is not new in the life sciences sector. Clinical research outsourcing, contract sales...

05
Oct2015

Navitas Announces Inaugural Clinical Data Strategy Network cdsnet

Navitas is excited to announce a new edition to their industry leading networks portfolio...

10
Sep2015

Navitas Introduces Innovative Regulatory Process Outsourcing Model

The workload for regulatory functions of pharmaceutical companies has continued to increase in recent...